- Home
- STOK vs AMBR Comparison
STOK vs AMBR Comparison
Compare STOK & AMBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- AMBR
- Stock Information
- Founded
- STOK 2014
- AMBR N/A
- Country
- STOK United States
- AMBR Singapore
- Employees
- STOK N/A
- AMBR N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- AMBR
- Sector
- STOK Health Care
- AMBR
- Exchange
- STOK Nasdaq
- AMBR NYSE
- Market Cap
- STOK 740.9M
- AMBR 715.7M
- IPO Year
- STOK 2019
- AMBR N/A
- Fundamental
- Price
- STOK $12.85
- AMBR $7.12
- Analyst Decision
- STOK Strong Buy
- AMBR
- Analyst Count
- STOK 5
- AMBR 0
- Target Price
- STOK $27.75
- AMBR N/A
- AVG Volume (30 Days)
- STOK 763.5K
- AMBR 223.1K
- Earning Date
- STOK 08-06-2025
- AMBR 08-15-2025
- Dividend Yield
- STOK N/A
- AMBR N/A
- EPS Growth
- STOK N/A
- AMBR N/A
- EPS
- STOK 0.88
- AMBR N/A
- Revenue
- STOK $190,908,000.00
- AMBR $5,038,151.00
- Revenue This Year
- STOK $378.84
- AMBR $15,062.49
- Revenue Next Year
- STOK N/A
- AMBR $12.11
- P/E Ratio
- STOK $14.68
- AMBR N/A
- Revenue Growth
- STOK 2333.81
- AMBR N/A
- 52 Week Low
- STOK $5.35
- AMBR $6.22
- 52 Week High
- STOK $16.15
- AMBR $13.09
- Technical
- Relative Strength Index (RSI)
- STOK 55.41
- AMBR N/A
- Support Level
- STOK $12.25
- AMBR N/A
- Resistance Level
- STOK $13.12
- AMBR N/A
- Average True Range (ATR)
- STOK 0.82
- AMBR 0.00
- MACD
- STOK -0.06
- AMBR 0.00
- Stochastic Oscillator
- STOK 35.70
- AMBR 0.00
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About AMBR AMBER INTERNATIONAL HOLDING LTD SPO SPON ADS EACH REP 5 ORD SHS (POST SPLIT)
Amber International Holding Ltd is a Web3 financial solutions and infrastructure provider, operating under the brand name Amber Premium. It provides institutional market access, execution infrastructure, and investment solutions to help institutions and high-net-worth individuals optimize their digital asset portfolios. Amber Premium offers a regulated, scalable financial ecosystem powered by proprietary trading technology, AI-driven risk management, and quantitative algorithms across CeFi, DeFi, and OTC markets.